Integrated Software Platform Development

About Mediso

Mediso is an established, privately-held developer of sophisticated hybrid molecular imaging systems for both clinical and preclinical applications. Its core strength lies in integrated platforms like the AnyScan® TRIO (SPECT/CT/PET) and the cryogen-free nanoScan® PET/MRI, with a strategic focus on the growing theranostics and quantitative imaging markets. The company has demonstrated steady growth through product launches, FDA software approvals, and geographic expansion into key Western European and North American markets via subsidiaries and partnerships.

Therapeutic Areas